Jill M. Kolesar
Affiliations: | Pharmacy Practice and Science | University of Kentucky, Lexington, KY |
Google:
"Jill Kolesar"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Schweer D, Anand N, Anderson A, et al. (2023) Human macrophage-engineered vesicles for utilization in ovarian cancer treatment. Frontiers in Oncology. 12: 1042730 |
| Larson KL, Huang B, Chen Q, et al. (2020) EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky. Plos One. 15: e0237790 |
| Roubal K, Myint ZW, Kolesar JM. (2020) Erdafitinib: A novel therapy for FGFR-mutated urothelial cancer. American Journal of Health-System Pharmacy. 77: 346-351 |
| McCorkle R, Gorski JW, Anderson A, et al. (2020) Abstract A50: Lapatinib potentiates the antitumor effects of paclitaxel treatment in resistant ovarian cancer cells Clinical Cancer Research. 26 |
| Kolesar JM, Andrews S, Green H, et al. (2019) A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose and Steady State Pharmacokinetics Study of 9cUAB30 in Healthy Volunteers. Cancer Prevention Research (Philadelphia, Pa.) |
| Nichols D, Arnold S, Weiss HL, et al. (2019) Pharmacogenomic potential in advanced cancer patients. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 76: 415-423 |
| Riess JW, Groshen SG, Reckamp KL, et al. (2019) Osimertinib (Osi) plus necitumumab (Neci) in EGFR-mutant NSCLC: An ETCTN California cancer consortium phase I study. Journal of Clinical Oncology. 37: 9057-9057 |
| Appleman LJ, Puligandla M, Pal SK, et al. (2019) Randomized, double-blind phase III study of pazopanib versus placebo in patients with metastatic renal cell carcinoma who have no evidence of disease following metastasectomy: A trial of the ECOG-ACRIN cancer research group (E2810). Journal of Clinical Oncology. 37: 4502-4502 |
| Becher OJ, Millard NE, Modak S, et al. (2017) A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors. Plos One. 12: e0178593 |
| Engle JA, Traynor AM, Campbell TC, et al. (2017) Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical center. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 1078155217704989 |